UPCOMING MRNS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit!Accesswire • 07/23/24
Shareholders of Marinus Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 5, 2024 to Discuss Your Rights – MRNSAccesswire • 07/22/24
Shareholders that lost money on Marinus Pharmaceuticals, Inc.(MRNS) should contact The Gross Law Firm about pending Class Action - MRNSGlobeNewsWire • 07/22/24
Class Action Filed Against Marinus Pharmaceuticals, Inc. (MRNS) - August 5, 2024 Deadline to Join - Contact Levi & KorsinskyAccesswire • 07/21/24
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNSGlobeNewsWire • 07/20/24
Contact Levi & Korsinsky by August 5, 2024 Deadline to Join Class Action Against Marinus Pharmaceuticals, Inc. (MRNS)Accesswire • 07/19/24
Faruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on August 5, 2024 in Marinus LawsuitPRNewsWire • 07/19/24
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Fraud Lawsuit Filed by The Rosen Law FirmPRNewsWire • 07/19/24
Marinus Pharmaceuticals Inc Is Under Investigation By The Schall Law Firm Which Urges Impacted Investors To Initiate ConversationsAccesswire • 07/18/24
Shareholders that lost money on Marinus Pharmaceuticals, Inc. (MRNS) should contact Levi & Korsinsky about pending Class Action - MRNSAccesswire • 07/18/24
Marinus Pharmaceuticals Announces Ganaxolone Approved in China as First Treatment for Seizures Associated with CDKL5 Deficiency DisorderBusiness Wire • 07/18/24
The Schall Law Firm Starts An Investigation Into Marinus Pharmaceuticals Inc And Encourages Affected Investors To Begin DialogueAccesswire • 07/17/24
Marinus Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Marinus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 – MRNSAccesswire • 07/17/24
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNSGlobeNewsWire • 07/17/24
Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 5, 2024 to Discuss Your Rights - MRNSPRNewsWire • 07/17/24
Levi & Korsinsky Notifies Shareholders of Marinus Pharmaceuticals, Inc.(MRNS) of a Class Action Lawsuit and an Upcoming DeadlineAccesswire • 07/16/24
The Schall Law Firm Commences A Probe Into Marinus Pharmaceuticals Inc And Urges Impacted Investors To Initiate DiscussionAccesswire • 07/16/24
Levi & Korsinsky Notifies Marinus Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – MRNSGlobeNewsWire • 07/16/24
Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MRNSAccesswire • 07/15/24
The Gross Law Firm Reminds Marinus Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 – MRNSGlobeNewsWire • 07/15/24
MRNS SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit!Accesswire • 07/14/24
The Schall Law Firm Initiates An Inquiry Into Marinus Pharmaceuticals Inc And Urges Impacted Investors To Start ConversationAccesswire • 07/13/24
ROSEN, A LEADING AND RANKED FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNSGlobeNewsWire • 07/13/24
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Fraud LawsuitPRNewsWire • 07/11/24
The Schall Law Firm Begins A Probe Into Marinus Pharmaceuticals Inc And Urges Impacted Investors To Initiate CommunicationAccesswire • 07/11/24
